Jessiesmom. You have no real rush for an updated genetic test. Which is in essence exactly the point of your post. I was rather surprised to see no difference from the discoveries between my test in 2002 and 2012. When I thought about it, 1% of the CF population which amounts to about 3,000 people in the U.S. are affected by possibly 3000 mutations so it isn't such a leap that odds were against a new discovery.
You might be happy to know National Jewish may soon have in-house genetic analysis if not already now. Maybe by 2014 a ten year test might be good in case. Don't be surprised if nothing new is found but if you can get a full screening it will have value soon enough.
It is a big project but designing 2000 genetic medicines for 2000 CF mutations is not going to happen. Rather the next step for a genetic medicine is a whole gene swap. Right now Kalydeco can eliminate the symptoms of CF for G331D (I am going from memory so I hope its the right one) by swapping out an glycine (G) for aspartic acid (D) so the basic pieces are assembled for a single CF drug. In two years CF could be a thing of the past. I wouldn't bet money on that prediction.
LL
Jessiesmom, if I were you, I would definitely be trying to actively find out the CF mutations present in your child.
Point 1) Here's a list of mutations, that kalydeco has shown some promise with in the lab. You might expect, with some luck, to see some effects in the patient:
(Minimal but some effect): L927P, E92K, M1V, F508del, H1054D, I336K, R334W, T338I, R1066H.
(Moderate to Good effect): R352Q, R117C, L206W, R347H, S977F, S945L, A455E, F1074L, E56K, P67L, R1070W, D110H, D579G, D110E, R1070Q, L997F, A1067T, E193K, R117H, R74W, K1060T, R668C, D1270N, D1152H, S1235R, F1052V.
Many of these mutations are not that common and may not come to light with a normal CFTR screen. Suppose your daughter has one of these?
Point 2) As Littlelab has pointed out, we are at the dawn of the genetic medicine age (i.e. use specific drug X for mutation Y). So, a doctor (and more importantly, a health insurance company) is going to turn around and say, hmm if we knew what the mutations were, we could put you (or insurance company pay) on drug x,y or z. So then you may find yourself in the position of having to wait and wait for various genetic tests to come back while a perfectly good drug is sitting on the shelf unused...